Preclinical study of reproductive toxicity of a drug based on an aqueous solution of fullerene С60 for the treatment of food allergies
Authors:
- Elena V. KovalevaEKElena V. Kovaleva
- Yulia V. IvanovaYIYulia V. Ivanova
- Nikolay M. OnatskyNONikolay M. Onatsky
- Vitaliia A. ShangaraevaVSVitaliia A. Shangaraeva
- Denis S. GorsheninDGDenis S. Gorshenin
- Elena N. BaraboshkinaEBElena N. Baraboshkina
- Anastasiia A. GalkinaAGAnastasiia A. Galkina
- Darya K. BolyakinaDBDarya K. Bolyakina
- Veronika A. ParshinaVPVeronika A. Parshina
- Renata A. KurmashevaRKRenata A. Kurmasheva
- Nadezda N. ShershakovaNSNadezda N. Shershakova
- Larisa V. MikhinaLMLarisa V. Mikhina
- 3 June 2025
- journal article
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 22 (2) , 153-164
Abstract
BACKGROUND: The incidence of food allergy in adults and children is very high. The key approach in the therapy of food allergy can be quality drug selection. New synthetic derivatives of fullerene, a high-tech hydrocarbon, can become such drugs. A unique biocompatible method for obtaining a stable aqueous dispersion of fullerene C60 (ADF-C60) as the main component for drugs for the treatment of allergic diseases has been developed. In this article, reproductive toxicity of the drug ADF-C60, currently in preclinical safety studies, was studied in female white outbred rats. Due to its properties, the ADF-C60 is promising for treatment of food allergy and can presumably be used during pregnancy. AIM: Preclinical study of reproductive toxicity of an ADF-C60 in the antenatal and postnatal periods of rat offspring development with oral administration to the mother generation during pregnancy. MATERIALS AND METHODS: Female rats were orally administered the ADF-C60 in 1-, 5-, and 50-fold therapeutic doses recommended for humans during the whole pregnancy. The general parameters of embryotoxic and teratogenic effects of the ADF-C60 before and after birth were studied. RESULTS: No evidence of embryotoxic and teratogenic effects of the ADF-C60 was found during the study of gestational parameters and general fetuses development. No adverse effects of the ADF-C60 were revealed during observation of postnatal development of offspring. CONCLUSION: ADF-C60 for the treatment of food allergy has no reproductive toxicity at doses up to 50 times higher than the therapeutic dose. After the conducted experiments it is possible to assume a significant probability of using the ADF-C60 during pregnancy, but additional preclinical and clinical studies are required to substantiate the obtained conclusion.Keywords
This publication has 27 references indexed in Scilit:
- Wound healing activity of aqueous dispersion of fullerene C60 produced by “green technology”Nanomedicine: Nanotechnology, Biology and Medicine, 2022
- Biocompatibility, antioxidant activity and collagen photoprotection properties of C60 fullerene adduct with L-methionineNanomedicine: Nanotechnology, Biology and Medicine, 2022
- Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genesBiochemical and Biophysical Research Communications, 2005
- [60]Fullerene is a Powerful Antioxidant in Vivo with No Acute or Subacute ToxicityNano Letters, 2005
- Fullerene derivatives: an attractive tool for biological applicationsEuropean Journal of Medicinal Chemistry, 2003
- Photo-induced cytotoxicity of malonic acid [C60]fullerene derivatives and its mechanismToxicology in Vitro, 2002
- Light-Independent Inactivation of Dengue-2 Virus by Carboxyfullerene C3 IsomerVirology, 2000
- C60 and Water-Soluble Fullerene Derivatives as Antioxidants Against Radical-Initiated Lipid PeroxidationJournal of Medicinal Chemistry, 1999
- Carboxyfullerenes as neuroprotective agentsProceedings of the National Academy of Sciences, 1997
- The extent of fetal ossification as an index of delayed development in teratogenic studies on the ratTeratology, 1979